The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 2,004.00
Ask: 2,006.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,008.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Stocks Set To Follow US And Asian Stocks Lower

Wed, 12th Mar 2014 07:38

LONDON (Alliance News) - UK stocks are set to open lower Wednesday, following on from weak sessions in the US and Asia, as investors continue to be starved of significant fresh data releases.

Meanwhile, a host of FTSE 100-listed companies have gone ex-dividend which is set to further weigh on the UK's blue-chip index Wednesday.

"Are investors starting to exhibit the first signs of concern that maybe the run higher in US equity markets and broader markets has run its course?" asks Michael Hewson, chief market analyst at CMC Markets.

The ongoing crisis in Ukraine and continued fears about a slowdown in China's economy continue to weigh heavy on investors shoulders.

Wall Street closed firmly lower on Tuesday, with the DJIA, NASDAQ Composite and S&P 500 down between 0.4 % and 0.5%.

Asian stocks have followed suit, with the Hang Seng and Shanghai Composite index trading down 1.6% and 0.2% prior to the UK equity market open. The Nikkei in Tokyo closed down 2.6% after the Japanese Cabinet Office revealed that confidence among Japanese households deteriorated for the third consecutive month in February.

The headline consumer confidence index dropped sharply to 38.2 in February from the downwardly revised 40.4 in January, missing expectations of a more modest decline to 40 from the originally reported 40.5.

In London, the FTSE 100 is indicated to open firmly lower by CMC Markets and IG, having closed at 6,685.52 on Tuesday. CMC Markets expects the index to open down at approximately 6,643 points, while IG indicates an even-lower opening level of 6,635.

In a light data calendar Wednesday, early focus will be on industrial production figures for the euro area at 1000 GMT.

Eurozone industrial production is expected to report a rise of 0.5% month-on-month in January, rebounding from a 0.7% decline in December. On a yearly basis, industrial production is forecast to rise by 1.9%, up from the 0.5% recorded in December.

"While this morning?s data is expected to point to continued modest recovery in the euro area, it is unlikely to make an impact on monetary policy expectations given European Central Bank President Draghi?s comments last week that monetary policy in the euro area will remain unchanged over the near term," says Carl Paraskevas, senior international macroeconomist at Lloyds Bank.

Also in the data calendar, US MBA mortgage applications information for the week ended March 7 is released at 1100 GMT. US Treasury Secretary Jack Lew gives a speech at 1800 GMT. There is no significant UK data scheduled.

In corporate news, FTSE 250-listed Ferrexpo and Hikma Pharmaceuticals, amongst others, have released full-year results for 2013 Wednesday. Ocado Group has released an interim management statement. Prudential is scheduled to release its full-year 2013 results at approximately 0815 GMT.

Pets at Home and Poundland will become the third and fourth British retailers to list in 2014 when conditional dealings start Wednesday.

Meanwhile, a large number of blue-chip companies have gone ex-dividend Wednesday, meaning that new buyers no longer qualify for the latest dividend payout from the company. The list includes HSBC, Standard Chartered, British American Tobacco, Meggitt, Randgold Resources, Land Securities, Hammerson, and Hargreaves Lansdown.

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.